US Patent 10323026 Heterocyclic compound
Patent 10323026 was granted and assigned to Takeda Pharmaceutical Company on June, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10323026 Heterocyclic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.